Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Minimally invasive liver surgery for perihilar and intrahepatic cholangiocarcinoma].

Chirurgie (Heidelberg, Germany)·2026
Same author

[Meta-analysis: robot-assisted vs. laparoscopic liver resection for early stage HCC].

Chirurgie (Heidelberg, Germany)·2026
Same author

[Results of the EuroLVD registry on liver venous deprivation before major liver resection].

Chirurgie (Heidelberg, Germany)·2026
Same author

[Operative and oncological outcomes after vascular resection for perihilar cholangiocarcinoma].

Chirurgie (Heidelberg, Germany)·2026
Same author

[The risk of recurrence of repeated resections of colorectal liver metastases].

Chirurgie (Heidelberg, Germany)·2025
Same author

[Primary small bowel malignancies].

Chirurgie (Heidelberg, Germany)·2025

Related Experiment Video

Updated: May 10, 2026

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

Supporting liver transplantation by clinical pathway intelligence.

K Kirchner1, Ch Malessa, N Herzberg

  • 1University Hospital Jena, Department of General, Visceral and Vascular Surgery, Jena, Germany.

Transplantation Proceedings
|June 18, 2013
PubMed
Summary

This study details an electronic clinical pathway for liver transplantation (LT) to enhance hospital quality. The system enables real-time patient monitoring and retrospective analysis of LT treatments for improved safety and resource management.

More Related Videos

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure

Published on: August 14, 2017

Related Experiment Videos

Last Updated: May 10, 2026

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure

Published on: August 14, 2017

Area of Science:

  • Medical Informatics
  • Healthcare Management
  • Surgical Quality Improvement

Background:

  • Reproducible and transparent clinical treatment quality is crucial for hospital performance, patient safety, and resource management.
  • Liver transplantation (LT) requires stringent quality control due to its complexity and impact on patient outcomes.
  • Existing systems may lack integrated data for comprehensive process monitoring and analysis in LT.

Purpose of the Study:

  • To develop and implement an electronic clinical pathway for liver transplantation (LT).
  • To enable real-time process monitoring and retrospective analysis of LT treatments.
  • To improve quality management, patient safety, and resource planning in LT.

Main Methods:

  • Documented the clinical pathway for LT in an electronic format within the PIGE research project.
  • Linked data from clinical information systems to the electronic pathway.
  • Utilized the integrated data for process monitoring and retrospective treatment analysis.

Main Results:

  • Established an electronic system for LT clinical pathway documentation.
  • Enabled continuous assessment of patient status within the LT process.
  • Facilitated detailed retrospective analysis of LT treatments, including cost, time, and personnel data.

Conclusions:

  • The electronic clinical pathway enhances transparency and reproducibility in LT care.
  • Integrated data systems support effective process monitoring and quality management in LT.
  • This approach offers valuable insights for optimizing LT patient care and hospital operations.